The drugmaker that hopes to legalize MDMA is cutting 75% of its staff after the FDA rejected the drug

Tech Insider
ptsd meds
The FDA rejected Lykos' MDMA drug for PTSD treatment.

Getty Images

Subscribe to pharmaceuitcals